Multicenter study of the treatment of erectile dysfunction with transurethral alprostadil (MUSE) in Korea

International Journal of Impotence Research

Volumn 12, Issue 2, 2000, Pages 97-101

  Kim, S C ^a   Ahn, T Y ^a   Choi, H K ^a   Choi, N G ^a   Chung, T G ^a   Chung, W S ^b   Hwang, T K ^a   Hyun, J S ^a   Jung, G W ^a   Kim, C I ^a   Kim, J J ^a   Kim, S W ^a   Lee, C H ^a   Lee, K S ^a   Lee, W H ^a   Min, K S ^a   Moon, K H ^a   Paick, J S ^a   Park, K S ^a   Park, N C ^a   Park, Y K ^a   Seo, J K ^a   Seo, K K ^a   Shin, J S ^a   Yoon, Y R ^c   Lee, W C ^d   more..

^a Department of Urology ^*  (South Korea)

^b Ewha Womans University   (South Korea)

^c Chungnam National University College of Medicine   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Efficacy; Erectile dysfunction; Safety; Transurethral alprostadil

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; ERECTILE DYSFUNCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PENIS ERECTION; PRIORITY JOURNAL; SOUTH KOREA; TREATMENT INDICATION;

EID: 0033835005     PISSN: 09559930     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijir.3900490     Document Type: Article

References (14)

1. The rationale for prostaglandin E1 in erectile failure: A survey of worldwide experience
2. Intracavernous pharmacotherapy: Treatment for the aging erectile response
3. Long-term follow-up of patients with erectile dysfunction commenced on self injection with intracavernosal papaverine with or without phentolamine
4. Predictors of success and risk factors for attrition in the use of intracavernous injection
5. Long-term follow-up of patients receiving injection therapy for erectile dysfunction
6. Treatment of men with erectile dysfunction with transurethral alprostadil
7. Efficacy and safety of transurethral alprostadil therapy in men with erectile dysfunction
8. Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting
9. Topical prostaglandin E1 for the treatment of erectile dysfunction
10. Hemodynamic effects of transurethral alprostadil measured by color duplex ultrasonography in men with erectile dysfunction
11. Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy
12. Long-term safety profile of transurethral alprostadil for the treatment of erectile dysfunction
13. One-year study of transurethral alprostadil for erectile dysfunction: Efficacy, safety, and satisfaction
14. Transurethral alprostadil with MUSE vs intracavernous alprostadil - A comparative study in 103 patients with erectile dysfunction